Over 2 years (FY 2023 to FY 2025), AVS — Acquisitions shows a downward trend with a -100.0% CAGR.
High levels indicate an aggressive growth strategy, while low levels may suggest a focus on organic growth or cash preservation.
The capital deployed by the segment to purchase other businesses, technologies, or product lines to expand market share...
Standard metric for tracking inorganic growth investments across the medical technology sector.
gehc_segment_avs_acquisitions| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.50M | $23.50M | $23.50M | $23.50M | $10.50M | $10.50M | $10.50M | $10.50M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -55.3% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — |
| YoY Change | — | — | — | — | -55.3% | -55.3% | -55.3% | -55.3% | -100.0% | -100.0% | -100.0% | -100.0% | — |